Psychedelic drug development beyond mental health. TRYP THERAPEUTICS CSE:TRYP | OTC:TRYPF Psychedelic stock Tryp Therapeutics is pursuing vast market potential by targeting chronic pain and other...
healthcare
Q4 2021 top Healthcare stocks to consider
Investing in the healthcare sector has become more popular since the Covid-19 pandemic arrived. With global health an essential item on every political agenda, it's obvious why. Healthcare can be a...
The biotech company ready to revolutionize mental healthcare
CYBIN | NEO:CYBN | NYSE:CYBN With over 700m people suffering from mental health disorders globally, a solution is desperately needed. Thankfully, there are some incredible companies...
This undervalued stock is developing biotechnology-enhanced therapeutics to treat mental health.
Hot biotech stock! Discover how Cybin is revolutionizing mental health care CYBIN NEO:CYBN | AMEX:CYBN Cybin is a therapeutics biotech firm targeting the rapidly evolving mental...
Growth of Gage – Set to become market leader in fastest growing state
Gage just keeps on growing - Q2 results are set to be record breaking GAGE GROWTH CORP. CSE:GAGE | OTC:GAEGF With consistently strong sales, a unique business model and quality...
Healthcare growth stocks to consider
Growth stocks are shares in an organisation that an investor expects will increase in value at a rate that’s higher than the average growth of the market. Alongside value investing, growth investing...
Havn Life Laying the Groundwork for this Industry’s Projected $11 Billion Comeback Story
Capturing Media's Attention HAVN LIFE SCIENCES INC. CSE: HAVN | OTC: HAVLF | FRA: 5NP This fast-growing market first began in the 1960s, but it's been completely forgotten about until just recently....
Gage Growth Corp. Announces Fiscal Year 2020 Results and Provides Business Update
Full Year 2020 revenue increased 1,972% year-over-year to $39.9 millionQ4 2020 revenue increased 615% year-over-year to $10.5 millionEnded 2020 with over $45 million of cash after...
Tiziana plans to list promising Accustem cancer test business on Nasdaq (TLSA) (TILS)
Tiziana Life Sciences (NASDAQ:TLSA | LSE: TILS) on Tuesday unveiled plans to list Accustem Sciences in the US on the Nasdaq Stock Market. This will give the spin-off access to a market with a...